GOLDMAN SACHS GROUP INC - SYNTHETIC BIOLOGICS INC ownership

SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U102. A total of 44 filers reported holding SYNTHETIC BIOLOGICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of SYNTHETIC BIOLOGICS INC
ValueSharesWeighting
Q2 2017$639,000
+7000.0%
1,129,108
+8102.7%
0.00%
Q1 2017$9,000
-81.2%
13,765
-51.0%
0.00%
Q3 2016$48,000
+140.0%
28,088
+157.2%
0.00%
Q2 2016$20,000
-92.0%
10,922
-89.7%
0.00%
Q1 2016$249,000
+336.8%
105,638
+322.3%
0.00%
Q4 2015$57,000
+3.6%
25,015
+0.1%
0.00%
Q1 2015$55,000
+189.5%
24,989
+96.8%
0.00%
Q4 2014$19,000
-77.4%
12,697
-73.0%
0.00%
Q3 2014$84,000
-2.3%
46,970
-5.7%
0.00%
Q2 2014$86,000
-33.3%
49,812
-0.7%
0.00%
Q1 2014$129,000
+158.0%
50,182
+54.1%
0.00%
Q4 2013$50,00032,5730.00%
Other shareholders
SYNTHETIC BIOLOGICS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 2,034,949$1,553,0002.72%
Third Security, LLC 13,238,268$10,095,0000.54%
MSD Partners, L.P. 4,118,402$3,141,0000.16%
SABBY MANAGEMENT, LLC 3,031,953$2,312,0000.13%
Alyeska Investment Group, L.P. 10,000,000$7,626,0000.06%
BARD ASSOCIATES INC 87,999$67,0000.03%
Alyeska Investment Group, L.P. 4,586,592$3,498,0000.03%
FRANKLIN STREET ADVISORS INC /NC 126,000$96,0000.02%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 1,000,000$763,000,0000.02%
HAMILTON LANE ADVISORS LLC 23,855$18,0000.01%
View complete list of SYNTHETIC BIOLOGICS INC shareholders